Prescription Required
Authentic Product
India's Leading Generic Pharmacy
Secure Payment
By CIPLA PHARMACEUTICAL COMPANY LIMITED
MRP
₹
119500
₹116150
2.8 % OFF
Check Delivery
--
Composition
Pregnancy
CONSULT YOUR DOCTORThere is limited information on the safety of CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION during pregnancy. Inform your physician if you are pregnant, suspecting, or planning for pregnancy
Clinical studies have shown that CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION can significantly reduce the risk of hospitalization or death in high-risk individuals with COVID-19. However, the effectiveness may vary depending on individual factors, including the illness's severity and specific variants of the virus.
CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION can be used alone or in combination with other COVID-19 treatments as determined by healthcare professionals. It is important to consult with healthcare providers to ensure proper coordination of treatments and minimize any potential interactions.
CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION is most effective when administered early after testing positive for COVID-19, ideally within 10 days of symptom onset. Early treatment helps reduce the severity of illness and the risk of hospitalization.
Yes, CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION is authorized for use in pediatric patients aged 12 years and older who weigh at least 35.5kg and are at high risk of developing severe COVID-19.
No, CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION is not a substitute for COVID-19 vaccination. Vaccination is the most effective way to prevent COVID-19 and its complications. This injection is specifically used to treat individuals who have already tested positive for the virus and are at high risk of developing the infection.
Information on specific drug interactions should be discussed with a healthcare professional. They can determine if CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION can be used safely with any other medications you are taking.
Self isolate and use infection control measures (eg, wearing mask, social distancing, avoid sharing personal items, clean and disinfecting “high touch” surfaces, and frequent handwashing). The most common side effects may include infusion-related reactions such as swelling in the hands, face, and feet, skin rash, breathing difficulties, cough, abdominal pain, and chest pain. Injection site reactions like swelling and redness at the injection site can also occur.
The active ingredients in CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION are Casirivimab and Imdevimab.
CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION is used as an antiviral treatment for COVID-19.
Yes, CASIRIVIMAB IMDEVIMAB REGN-COV2 INJECTION is an antiviral medication used to treat COVID-19.
Proper medicine at big saving rate
Mukesh Jain
•
Reviewed on 24-01-2024
(5/5)
Genuine products
monalisha satapathy
•
Reviewed on 05-08-2023
(5/5)
Very good service and discount
Yatin Patel
•
Reviewed on 13-01-2024
(5/5)
Best for medicine and helpfull.😊
Dilip Darji
•
Reviewed on 02-02-2024
(5/5)
Very cheap, helpful, friendly service
Milind Patel
•
Reviewed on 10-02-2023
(5/5)
CIPLA PHARMACEUTICAL COMPANY LIMITED
Country of Origin -
India
MRP
₹
119500
₹116150
2.8 % OFF
Quick Links
Medkart's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, medicines, generic alternatives, all possible side effects, drug interactions, warnings, alerts, lab tests, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.
10 Lakh+
Happy customers
35000+
Pin-codes Covered
75 Lakh+
Orders Delivered
Authentic Products
All WHO-GMP Certified Medicines
©2025 Medkart Pharmacy. All Rights Reserved
